August 19, 2013

Specialty pharmacy CareMed Pharmaceutical Services has been added to a limited-distribution network for a cancer drug sold by Genentech and Astellas Pharma, the company said.

July 24, 2013

Mylan has settled with the makers of a drug used to treat cancer in a patent-infringement lawsuit, the generic drug maker said.

July 2, 2013

BioPlus Specialty Pharmacy has been added to the limited-distribution network for a Genentech drug used to treat lung and pancreatic cancers.

July 2, 2013

A cancer drug made by Genentech and Astellas is no longer available through ordinary retail channels and is now available only through a limited-distribution network.

June 18, 2013

Avella Specialty Pharmacy will be included in the limited-distribution network for a cancer drug made by Genentech, Avella said Tuesday.

May 15, 2013

The Food and Drug Administration has approved a drug for a type of lung cancer.

May 3, 2012

Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.

March 16, 2012

Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.

December 9, 2010

An investigational treatment for lung cancer made by Boehringer Ingelheim Pharmaceuticals extended patients’ survival by more than four months, according to results of a late-stage clinical trial announced Thursday.

August 26, 2010

Pfizer reported mixed results this week in a late-stage clinical trial combining two drugs in...

June 7, 2010

Japanese drug maker Astellas Pharma has completed its acquisition of OSI Pharmaceuticals, Astellas said Tuesday....

May 16, 2010

Japanese drug maker Astellas Pharma will acquire U.S.-based OSI Pharmaceuticals for $4 billion, the two...

March 11, 2010

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

March 4, 2010

One of the biggest holders of OSI Pharmaceuticals’ stock has said Japanese drug maker Astellas...

February 28, 2010

A Japanese drug maker hopes to buy up a pharmaceutical company based in New York...

January 18, 2010

The Food and Drug Administration has extended its review period for a lung cancer drug...

January 12, 2010

Researchers in Arizona have found a way to predict which patients might be resistant to...